A newly disclosed email from Janet Woodcock, former Acting Commissioner of the U.S. Food and Drug Administration (FDA), reveals internal warnings about severe vaccine-related adverse events that were systematically ignored by federal health officials. The document, obtained by Senators Ron Johnson and Rand Paul, shows Woodcock wrote to Drs. Anthony Fauci and Francis Collins on May 27, 2021, reporting direct patient reports of symptoms after COVID-19 vaccination.

Woodcock’s email states: “The symptoms do not fit together into a distinctive syndrome and most are not easily quantifiable or evaluated with standard laboratory testing.” She further noted that these issues “are not the sort that a system like VAERS would be able to detect, or even a more sophisticated population-based active followup such as CDC has, or a medical record based system such as BEST.” The email also includes Woodcock’s concern that health officials should investigate the problem but doubted industry cooperation: “I doubt the industry would support… If you let a problem fester, then it will come back to bite you later.”

The disclosure coincides with data showing 440,025 adverse events and 8,650 deaths linked to COVID-19 vaccinations reported to VAERS by May 27, 2021—3,350 of which occurred within two days. By that date, the FDA’s internal surveillance system had already exceeded its December 2020 projected daily reports by 2.6 times.

Johnson’s office notes that three months prior to Woodcock’s email, Dr. Ana Szarfman—a senior FDA official—had warned that the agency’s VAERS analysis algorithm was masking critical safety signals. Her monthly data runs identified dozens of concerning patterns, including sudden cardiac death, pulmonary infarction (which Dr. Fauci later experienced in June 2021), cerebral artery occlusion, basal ganglia stroke, agonal rhythm, and Bell’s palsy. Despite these warnings, FDA officials instructed Szarfman to cease her analysis.

Additionally, the email references ongoing efforts at the National Institutes of Health where doctors were diagnosing and treating patients with severe injuries consistent with reported vaccine-related symptoms. The disclosure raises questions about whether Woodcock was aware of these NIH treatments or internal FDA alerts when she wrote her May 27, 2021 email—and if so, why that knowledge remained undisclosed to the public.